Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cancer-associated venous thromboembolism in the direct oral anticoagulants era: Insight from the COMMAND VTE Registry-2.
Chatani R, Yamashita Y, Morimoto T, Mushiake K, Kadota K, Kaneda K, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Nishikawa R, Kimura T; COMMAND VTE Registry-2 Investigators. Chatani R, et al. Among authors: mushiake k. Thromb Res. 2024 Feb;234:86-93. doi: 10.1016/j.thromres.2023.12.016. Epub 2024 Jan 2. Thromb Res. 2024. PMID: 38190788
Transition of management strategies and long-term outcomes in cancer-associated venous thromboembolism from the warfarin era to the direct oral anticoagulant era.
Chatani R, Yamashita Y, Morimoto T, Kaneda K, Mushiake K, Kadota K, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Kimura T; COMMAND VTE Registry-2 Investigators. Chatani R, et al. Among authors: mushiake k. Eur J Intern Med. 2024 May;123:72-80. doi: 10.1016/j.ejim.2024.01.012. Epub 2024 Jan 25. Eur J Intern Med. 2024. PMID: 38278660
Home Treatment for Active Cancer Patients With Low-Risk Pulmonary Embolism　- A Predetermined Companion Report From the ONCO PE Trial.
Chatani R, Yamashita Y, Morimoto T, Muraoka N, Shioyama W, Shibata T, Nishimoto Y, Ogihara Y, Doi K, Oi M, Shiga T, Sueta D, Kim K, Tanabe Y, Koitabashi N, Takada T, Ikeda S, Nakagawa H, Mitsuhashi T, Shoji M, Sakamoto J, Hisatake S, Ogino Y, Fujita M, Nakanishi N, Dohke T, Hiramori S, Nawada R, Kaneda K, Mushiake K, Yamamoto H, Kadota K, Ono K, Kimura T; ONCO PE Trial Investigators. Chatani R, et al. Among authors: mushiake k. Circ J. 2024 Mar 8. doi: 10.1253/circj.CJ-24-0004. Online ahead of print. Circ J. 2024. PMID: 38462535 Free article.
Edoxaban for 12 vs. 3 months in cancer-associated isolated distal deep vein thrombosis according to different doses: insights from the ONCO DVT study.
Chatani R, Yamashita Y, Morimoto T, Muraoka N, Umetsu M, Nishimoto Y, Takada T, Ogihara Y, Nishikawa T, Ikeda N, Otsui K, Sueta D, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Tsukahara K, Nakanishi N, Kim K, Ikeda S, Mushiake K, Kadota K, Ono K, Kimura T. Chatani R, et al. Among authors: mushiake k. Eur Heart J Cardiovasc Pharmacother. 2024 Aug 14;10(5):422-431. doi: 10.1093/ehjcvp/pvae028. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38650055 Free PMC article. Clinical Trial.
Transition from WATCHMAN generation-2.5 device to WATCHMAN FLX device for percutaneous left atrial appendage closure: Incidence and predictors of device-related thrombosis and short- to mid-term outcomes.
Chatani R, Kubo S, Tasaka H, Nishiura N, Mushiake K, Ono S, Maruo T, Kadota K. Chatani R, et al. Among authors: mushiake k. Catheter Cardiovasc Interv. 2024 Aug;104(2):318-329. doi: 10.1002/ccd.31111. Epub 2024 Jun 19. Catheter Cardiovasc Interv. 2024. PMID: 38895767
31 results